Abacus Health Products to Present at the LD Micro Main Event (XII)

LOS ANGELES, CA / ACCESSWIRE / December 9, 2019 / Abacus Health Products, Inc. (CSE:ABCS)(OTCQX:ABAHF) ("Abacus" or the "Company") today announced that it will be presenting at the 12^th Annual LD Micro Main Event being held on December 10-12, 2019 at the Luxe Sunset Bel Air Hotel in Bel Air, California.

Jonathan Conforti, Vice President of Corporate Development, is scheduled to present on Wednesday December 11^th at 11:00am PST and available for one-on-one meetings during the conference.

Abacus' leading consumer brand, CBDMEDIC, includes a line of topical pain relief and skincare products. Abacus' leadership in the CBD market is underscored by its announcement that it has received purchase orders from approximately 7,000 retail locations representing 20 chains including the 3 largest national retail pharmacy chains. The Company recently announced growing distribution as well as a partnership with 3-time football world champion Rob Gronkowski and a branding agreement with Gillette Stadium and Patriot Place.

To schedule a one-on-one meeting with Abacus Health Products, you may submit your request online via the link provided upon registration or email your request to [email protected]. To register for the conference, contact David Scher at [email protected] or visit www.ldmicro.com/events.

"This year's Main Event is our largest event to date, with 275 companies set to present and meet with investors" stated Chris Lahiji, President of LD Micro. "Even though LD has emerged as one of the largest and most influential organizations in the space, our focus has never deviated from showcasing some of the more interesting businesses in the world to our ever-growing community. Investor interest in our events has also never been stronger, and that goes for our commitment to philanthropy as well."

The LD Micro Main Event will take place on December 10th-12th in Los Angeles It is one of the nation's largest independent conferences for micro-cap companies which will feature 275 companies, and will be attended by over 1,400 individuals.

View Abacus Health Product's profile here http://www.ldmicro.com/profile/ABAHF.

About Abacus Health Products, Inc.

Abacus is a company engaged in the development and commercialization of over-the-counter (OTC) topical medications with active pharmaceutical ingredients. Abacus' products contain organic and natural ingredients, including hemp extract or oil containing CBD from Cannabis Sativa L. plant. Abacus' products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending formulations to provide safe and effective relief. Abacus currently offers two lines of products: (i) CBD CLINIC™, marketed to the professional practitioner market, and (ii) CBDMEDIC™, marketed to the consumer market. Abacus' products are offered across the United States and are produced by a contract manufacturer in a cGMP compliant and audited manufacturing facility.

To learn more about Abacus, visit www.abacushp.com

For further information: please contact Hank Hague, CFO, of the Company, at 416-848-1457 or [email protected] Or Bill Mitoulas, Investor Relations, at [email protected] or 416.479.9547.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space.

What started out as a newsletter highlighting unique companies has transformed into several influential events annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.

For those interested in attending, please contact David Scher at [email protected] or visit www.ldmicro.com for more information.

SOURCE: Abacus Health Products via LD Micro